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Background: Early generation, drug-eluting stents are associated with an increased risk of very late (>1 year) stent thrombosis compared with 
bare-metal stents. There is limited data if the risk of very late stent thrombosis persists with newer-generation everolimus-eluting stents (EES) 
compared to sirolimus-eluting stents (SES).
methods: Of 2,774 patients, 1,390 patients were assigned to receive the EES, and 1,384 patients were assigned to receive the SES in the SORT 
OUT IV trial. Definite and probable stent thromboses were assessed within 3 years.
results: Definite stent thrombosis occurred within 3 years in 23 patients (0.8%) and definite/probable stent thrombosis occurred in 33 patients 
(1.2%). 
EES SES HR 95% CI
Definite stent thrombosis 3 (0.2%) 20 (1.4%) 0.15 (0.04 - 0.50)
Acute 0 (0.0%) 3 (0.3%) -
Subacute 2 (0.1%) 4 (0.3%) 0.50 (0.09 - 2.71)
Late 0 (0.0%) 2 (0.1%) -
Very Late 1 (0.1%) 11 (0.8%) 0.09 (0.01 - 0.70)
Probable stent thrombosis 7 (0.5%) 3 ( 0.2%) 2.32 (0.60 - 8.99)
Definite/probable stent thrombosis 10 (0.7%) 23(1.7%) 0.43 (0.21 - 0.91)
Definite stent thrombosis occurred within 3 years in 3 patients [0.2%] in the EES group and in 20 patients [1.4%] in the SES group (p = 0.002). Very 
late definite stent thrombosis occurred in 1 patients [0.1%] in the EES group and in 11 patients [0.8%] in the SES group (p = 0.021).
conclusion: EES showed a significant reduced risk of definite stent thrombosis compared to SES. Very late definite stent thrombosis, which was 
present with SES, was markedly reduced by EES.
